GlobalData Epidemiologist Report: Global Covid fatalities near 910,000 – infections pass 28.1 million
11 September Globally, the total confirmed cases of Covid-19 have reached over 28,170,000, with more than 909,000 deaths and 18,995,000…
Latest Special Focus
-
2 months
-
2 months
-
2 months
-
2 months
-
2 months
-
2 months
-
2 months
-
2 months
International update: Global Covid cases pass 28.1 million – Western Europe a new hotspot
11 September Global: Worldwide Covid-19 cases have now passed 28.1 million, with deaths exceeding 909,000 according to Johns Hopkins University.…
Latest News
View More
Boehringer initiates trial of targeted therapy to treat Covid-19 patients
Boehringer Ingelheim has initiated a Phase II clinical trial of a novel compound, BI 764198, for treating hospitalised Covid-19 patients with acute respiratory complications. BI…
Aurinia initiates voclosporin trial in KTRs with Covid-19
Aurinia Pharmaceuticals has initiated an open-label exploratory trial to analyse the antiviral effects of voclosporin in kidney transplant recipients (KTRs) with Covid-19. Aurinia also secured…
Prilenia begins patient enrolment in HD drug trial in US
Prilenia Therapeutics has enrolled the first patients in a Phase III trial of pridopidine for the treatment of Huntington’s Disease…
Olatec Therapeutics initiates enrolment in oral drug trial for Covid-19
Olatec Therapeutics has initiated patient enrolment in a Phase II trial to analyse the safety and efficacy of oral NLRP3…
HiFiBiO Therapeutics concludes first cohort of Covid-19 antibody study
HiFiBiO Therapeutics has successfully completed the first cohort of the Phase I trial (NCT04590430) of SARS-CoV-2 neutralising antibody, HFB30132A, to…
Novartis’ iptacopan reduces proteinuria in rare renal disease trial
Novartis has announced that interim analysis results from the Phase II trial of iptacopan (LNP023) showed the oral therapy significantly…
Latest Content
View MoreInternational update: Global Covid cases pass 27.1 million – India second most infected with 4.2 million
7 September Global: Global Covid-19 deaths have passed 889,000 with more than 27.1 million cases according to the Johns Hopkins…
How remote working can improve wellbeing and help control Covid-19
7 September Many companies across the world have opted for remote working operations to safeguard their business and employees. Remote…
WAKIX (pitolisant) for the Treatment of Cataplexy with Narcolepsy
WAKIX® (pitolisant) is the first and only non-scheduled medication indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS)…
Real Time Cargo Intelligence to Increase Distribution Quality and Security
Smooth visibility from the place of production to the ultimate destination must be the new standard for vaccine delivery. The…
SIMPONI ARIA (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA)
SIMPONI ARIA® (golimumab) is a fully human anti-tumour necrosis factor (TNF) alpha monoclonal antibody. It is indicated for the treatment…
SOM Biotech Announces Poster Presentation on the Repurposing of Eravacycline for the Treatment of SARS-CoV-2
SOM Biotech, a biopharmaceutical company specialising in the repositioning of existing drugs for the treatment of diseases with a high…